Private Advisor Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Sell |
|
|||||
|
2025
Q1 | $197K | Sell |
|
|||||
|
2024
Q4 | $565K | Sell |
|
|||||
|
2024
Q3 | $470K | Buy |
|
|||||
|
2024
Q2 | $376K | Buy |
|
|||||
|
2024
Q1 | $310K | Buy |
|
|||||
|
2023
Q4 | $204K | Buy |
|
|||||
|
2023
Q3 | $147K | Buy |
|
|||||
|
2023
Q2 | $97.7K | Sell |
|
|||||
|
2023
Q1 | $117K | Hold |
|
|||||
|
2022
Q4 | $120 | Sell |
|
|||||
|
2022
Q3 | $116K | Sell |
|
|||||
|
2022
Q2 | $185K | Buy |
|
|||||
|
2022
Q1 | $130K | Sell |
|
|||||
|
2021
Q4 | $121K | Sell |
|
|||||
|
2021
Q3 | $159K | Sell |
|
|||||
|
2021
Q2 | $162K | Buy |
|
|||||
|
2021
Q1 | $182K | Sell |
|
|||||
|
2020
Q4 | $180K | Sell |
|
|||||
|
2020
Q3 | $171K | Sell |
|
|||||
|
2020
Q2 | $271K | Buy |
|
|||||
|
2020
Q1 | $177K | Buy |
|
|||||
|
2019
Q4 | $187K | Sell |
|
|||||
|
2019
Q3 | $156K | Buy |
|
|||||
|
2019
Q2 | $223K | Sell |
|
|||||
|
2019
Q1 | $536K | Sell |
|
|||||
|
2018
Q4 | $600K | Buy |
|
|||||
|
2018
Q3 | $721K | Buy |
|
|||||
|
2018
Q2 | $204K | Sell |
|
|||||
|
2018
Q1 | $368K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $347K | Buy |
|
|||||
|
2017
Q2 | $357K | Sell |
|
|||||
|
2017
Q1 | $559K | Buy |
|
|||||
|
2016
Q4 | $578K | Buy |
|
|||||
|
2016
Q3 | $514K | Buy |
|
|||||
|
2016
Q2 | $554K | Buy |
|
|||||
|
2016
Q1 | $474K | Sell |
|
|||||
|
2015
Q4 | $639K | Buy |
|
|||||
|
2015
Q3 | $519K | Sell |
|
|||||
|
2015
Q2 | $707K | Buy |
|
|||||
|
2015
Q1 | $713K | Sell |
|
|||||
|
2014
Q4 | $689K | Buy |
|
|||||
|
2014
Q3 | $547K | Buy |
|
|||||
|
2014
Q2 | $449K | Buy |
|
|||||
|
2014
Q1 | $363K | Buy |
|